Average Co-Inventor Count = 6.79
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Chiesi Farmaceutici S.p.a. (12 from 328 patents)
2. Asterand UK Limited (9 from 10 patents)
3. Cancer Research Technology Limited (6 from 262 patents)
4. Vandria Sa (4 from 4 patents)
5. Antabio Sas (1 from 7 patents)
6. Pharmagene Laboratories Limited (1 from 4 patents)
33 patents:
1. 12473269 - Urolithin derivatives and methods of use thereof
2. 12358884 - Urolithin derivatives and methods of use thereof
3. 12351567 - Urolithin derivatives and methods of use thereof
4. 11820751 - Urolithin derivatives and methods of use thereof
5. 11680068 - Compounds useful as RET inhibitors
6. 11661423 - Heterocyclic compounds as RET kinase inhibitors
7. 11548896 - Heterocyclic compounds as RET kinase inhibitors
8. 11352361 - Compounds useful as RET inhibitors
9. 11000511 - Chemical compounds as antibiotics
10. 10954241 - Heterocyclic compounds as ret kinase inhibitors
11. 10844067 - Heterocyclic compounds as RET kinase inhibitors
12. 10172830 - Pyrazolone compounds having human neutrophil elastase inhibitory properties
13. 10023558 - Compounds
14. 9868740 - Pyrimidinone compounds which are HNE inhibitors
15. 9828382 - Pyrimidinone compounds as human neutrophil elastase inhibitors